Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 2,151.85
+121.15 (5.97%)
At close: Jun 1, 2026
Wockhardt Revenue
In the fiscal year ending March 31, 2026, Wockhardt had annual revenue of 33.73B INR with 11.14% growth. Wockhardt had revenue of 9.65B in the quarter ending March 31, 2026, with 25.98% growth.
Revenue
33.73B
Revenue Growth
+11.14%
P/S Ratio
9.79
Revenue / Employee
14.69M
Employees
2,296
Market Cap
330.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 33.73B | 3.38B | 11.14% |
| Mar 31, 2025 | 30.35B | 2.05B | 7.24% |
| Mar 31, 2024 | 28.30B | 1.73B | 6.51% |
| Mar 31, 2023 | 26.57B | -5.73B | -17.74% |
| Mar 31, 2022 | 32.30B | 5.22B | 19.28% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lupin | 279.58B |
| Jubilant Pharmova | 82.80B |
| Abbott India | 69.29B |
| Granules India | 53.66B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| GlaxoSmithKline Pharmaceuticals | 38.22B |
| Viyash Scientific | 34.20B |
| AstraZeneca Pharma India | 22.76B |
Wockhardt News
- 11 hours ago - Pharma Stocks Today, June 1: Wockhardt surges 12%, Natco Pharma crashes 6%, Glenmark Pharma down 3.63% - Business Upturn
- 11 hours ago - Wockhardt shares jump over 12% after US FDA approves Novel Antibiotic ZAYNICH - Business Upturn
- 2 days ago - Wockhardt receives U.S. FDA approval for ZAYNICH, a novel antibiotic for cUTI - Business Upturn
- 3 days ago - Top gainers today: netweb at ₹4,670.70 up 14.70%, wockhardt at ₹2,031.40 up 14.70%, thermax at ₹4,982.70 up 8.54% - Business Upturn
- 3 days ago - Top gainers in morning trade: netweb at ₹4,447 up 9.21%, wockhardt at ₹1,919.40 up 8.38%, thermax at ₹4,959.30 up 8.03% - Business Upturn
- 3 days ago - Pharma sector stocks today, May 29: Wockhardt jumps 7.40%, Indoco Remedies rises 3.46%, Sudeep Pharma up 3.45% - Business Upturn
- 4 days ago - Wockhardt receives marketing authorisation for breakthrough antibiotic Zaynich in India - Business Upturn
- 5 days ago - Pharma sector stocks today, May 27: Panacea Biotech rises 2.83%, Wockhardt up 2.71%, Aurobindo Pharma down 0.17% - Business Upturn